Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/11/868   
Active ingredient: Lenalidomide
Indication: Treatment of diffuse large B-cell lymphoma
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2011 Orphan designation EMA/OD/160/10 (2011)3494 of 13/05/2011
30/05/2011 Change of name and/or address of sponsor EMA/OD/160/10